Investor Lunch with Sweetch Co-Founder & Chief Medical Officer: Customization of Digital Health NEW YORK

Details

When:
February 25, 2016 @ 12:00 pm – 1:30 pm
Contact:
Where:
NEW YORK
Location

OurCrowd invites you for a lunch presentation featuring Dr. Yossi Bahagon, Co-Founder and Chief Medical Officer from Sweetch. Sweetch is aiming to create a digital vaccine for diabetes by combining predictive analytics with behavioral modification – all offered through a mobile health platform. Sweetch is poised to enter the lucrative and growing digital health sector.

The digital health sector, especially the part dealing with preventable and manageable diseases, and, specifically, the prediabetes space, promises not only better health for consumers but more-than-healthy returns for investors. The future is also especially promising for applications that can be scaled en masse and used globally, saving not only lives but also significant amounts of money on health care. Although in 2014 $1 out of every $5 of health-care spending in the United States was used to treat diabetes, which is the seventh-leading cause of death and affects 29 million people in the U.S., according to the American Diabetes Association, it should be remembered that the disease is often considered preventable. If an app like Sweetch can prevent people from even becoming diabetic in the first place, the savings on healthcare costs would be enormous. Sweetch’s app will soon begin clinical trials at Johns Hopkins University. The app is both definitive of and a great recipient of the momentum pushing the growth of the digital health sector.

Investor Lunch: Customization of Digital Health
Thursday, February 25th
12:00pm – 1:30pm
 To register, email Allison@ourcrowd.com
Kosher lunch will be served
Space is limited.

THE SPEAKER:

Yossi Bahagon, M.D.M.B.I, Co-Founder & Chief Medical Officer

A clinically active Family Physician, entrepreneur and a Key Opinion Leader in the fields of e-health, m-Health & Tele-Care. Dr. Bahagon founded and managed Clalit Health Services Digital Health Division which became the second largest Digital Health platform in the world, with over two million patients using it each month, for over four million interactions. Dr. Bahagon serves as an advisory board member of Biocat’s Digital Health Accelerator in Barcelona, Editorial Board Member of the UK eHealth Law & Policy Journal, and a mentor at Microsoft’s Think-Next Accelerator. Dr. Bahagon was a founding member of Israel’s leading digital health startups, all of which showed significant growth.


THE COMPANY:

Sweetch: preventive mobile health platform focused on pre-diabetics. Sweetch combines first-of-its-kind predictive analytics with a behavioral modification engine to help high-risk patients lower their risk of developing diabetes. Led by an accomplished, multi-disciplinary team, Sweetch is set to begin a pilot at Johns Hopkins in Q1 2016.  There are 29M diabetics in the US, with an estimated $245B in associated diabetes costs in 2012. Stakeholders throughout the healthcare industry are seeking any way to reduce diabetes incidence, driving focus to pre-diabetes, a state of slightly elevated blood sugar levels that has been estimated to impact 86M Americans. While there have been some efforts to standardize treatment of pre-diabetes, until now, there has been no reliable way to (1) predict who will actually develop diabetes and when, and (2) engage candidates in a scalable way. Sweetch’s behavioral modification algorithms use these inputs to provide contextual, relevant suggestions that guide patients toward key objectives of the Diabetes Prevention Program (DPP). The DPP was the result of a landmark study which showed that lifestyle changes which led to modest weight loss reduce risk of developing diabetes by 58%. As the first fully digital approach to diabetes prevention, Sweetch is able to continuously monitor user activity adherence and updates its individualized risk dashboard accordingly.

We look forward to seeing you there. Please contact Allison Spielman, allison@ourcrowd.com, with any questions.